NCT02816554View on ClinicalTrials.gov

Safety and Immunogenicity of JECEVAX in Young Children

PHASE2CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

September 30, 2015

Study Completion Date

November 30, 2015

Conditions
Japanese Encephalitis
Interventions
BIOLOGICAL

JEVAX

JEVAX - VABIOTECH Vietnam Liquid form Subcutaneous injection 0.5ml/dose, 2 doses, 10-12 days interval

BIOLOGICAL

JECEVAX-1

JECEVAX - VABIOTECH Vietnam Liquid form Composition: 1 BR209 Subcutaneous injection 0.5ml/dose, 2 doses, interval 10-12 days

BIOLOGICAL

JECEVAX-0.8

JECEVAX - VABIOTECH Vietnam Liquid form Composition: 0.8 BR209 Subcutaneous injection 0.5ml/dose, 2 doses, interval 10-12 days

BIOLOGICAL

JECEVAX-0.5

JECEVAX - VABIOTECH Vietnam Liquid form Composition: 0.5 BR209 Subcutaneous injection 0.5ml/dose, 2 doses, interval 10-12 days

Trial Locations (2)

Unknown

District Health Center, Thanh Sơn

Phu Tho Preventive Medicine Center, Việt Trì

All Listed Sponsors
collaborator

Ministry of Science and Technology, Vietnam

OTHER_GOV

collaborator

Ministry of Health, Vietnam

OTHER_GOV

lead

National Institute of Hygiene and Epidemiology, Vietnam

OTHER

NCT02816554 - Safety and Immunogenicity of JECEVAX in Young Children | Biotech Hunter | Biotech Hunter